Leerink Partners Raises Price Target on Bruker (BRKR) to $28 Following 1Q Beat
Leerink Partners reiterated a Market Perform rating on Bruker (NASDAQ: BRKR), and raised the price target to $28.00 (from $27.00) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)